Przejdź do komentarzy
Przejdź do komentarzy

Public activities coordination tool

Public activities coordination tool

The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.

PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:

  • Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
  • Regulatory management option analysis (RMOA).
  • Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, restriction.

A summary of the all the substance-specific activities can be found under ‘Details’ for each entry.

1,1'-(isopropylidene)bis[3,5-dibromo-4-(2,3-dibromopropoxy)benzene]

EC / List no: 244-617-5 CAS no: 21850-44-2
Data generation and assessment
DEv - Dossier evaluation
DEv 1
Scope
Comprehensive
Status
Concluded
Decision date
Decision
Latest update
13/10/2018
More information View
DEv 2
Scope
Testing Proposal
Status
Concluded
Decision date
03/03/2016
Decision
Latest update
04/10/2018
More information View
SEv - Substance evaluation (Community Rolling Action Plan (CoRAP))
SEv 1
Evaluating Member State
Germany
Co-Evaluating Member State
Initial grounds for concern
Potential endocrine disruptor
Suspected PBT/vPvB
High (aggregated) tonnage
Year
2017
Status
Ongoing
Conclusion document
Latest update
12/02/2019
More information View
PBT - Persistent, bioaccumulative and toxic assessment
PBT 1
Authority
Germany
Status
Under development
Outcome
Under development under SEV
Follow-up
No suggestion yet
Hazard assessment outcome document
Remarks
Concern
PBT (Article 57 d)
Date of intention
04/11/2015
Date of hazard assessment
Latest update
05/01/2018
More information View
ED - Endocrine disruptor assessment
ED 1
Authority
Germany
Status
Under development under SEV
Outcome
Under development under SEV
Follow-up
No suggestion yet
Hazard assessment outcome document
Remarks
Concern
Endocrine disruption
Date of intention
05/12/2017
Date of hazard assessment
Latest update
05/01/2018
More information View

Export search results to:

Categories Display

Oznakowane jako:

(kliknij znak, aby wyszukać właściwą treść)


Route: .live2